Verastem reported $-16980000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbvie ABBV:US $ 5029M 601M
AstraZeneca AZN:LN 2.88B 1.57B
Curis CRIS:US $ -15133000 2.57M
Cytokinetics CYTK:US $ -77857000 58.95M
Epizyme EPZM:US $ -50926000 360K
Gilead Sciences GILD:US $ 2897M 1957M
Immunogen IMGN:US $ -22852000 11.7M
Laboratory Of America LH:US $ 701.7M 54.6M
Novartis NOVN:VX 3.15B 266M
Pfizer PFE:US $ 9995M 4136M
Tg Therapeutics TGTX:US $ -66872000 26.08M
Verastem VSTM:US $ -16980000 469K
YTE INCY:US $ 127.66M 7.71M
Ziopharm Oncology ZIOP:US $ -9085000 1.23M